Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Lee, J. Lee, V. Lopez, G. Barr, M. Carnethon, D. Yanez, N. Wong (Irvine, New York, Chicago, Seattle, United States Of America). Impact of pulmonary function on cardiovascular disease events in persons with metabolic syndrome and diabetes. Eur Respir J 2011; 38: Suppl. 55, 1757

Member's Comments

No comment yet.

Related content which might interest you: Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Source: Eur Respir J 2008; 32: 962-969 Year: 2008 Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 The evaluation of systemic inflammation in COPD patients comorbided with cardiovascular diseases or diabetes mellitus Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Metabolic syndrome in COPD patients without cardiovascular comorbidities: Co-existence or a different COPD phenotype? Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 In people at high risk of cardiovascular disease, co-existing COPD is not independently associated with macrovascular or microvascular disease Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD Year: 2018 Prevalence of undiagnosed COPD in patients with established cardiovascular diseases Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010 Coexistence of cardiovascular diseases in patients with COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Effects of cardiovascular agents on respiratory function in COPD patients with concomitant coronary heart disease Source: Eur Respir J 2002; 20: Suppl. 38, 247s Year: 2002 Systemic consequences (cardiovascular, muscular and metabolic aspects) of chronic inactivity in chronic cardio-respiratory diseases including COPD Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD Year: 2011 Respiratory polygraphy patterns and risk of cardiovascular events in patients with acute coronary syndrome Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders Year: 2021 The metabolic syndrome and pulmonary hypertension Source: Virtual Congress 2020 – Pulmonary vascular diseases Year: 2020 Evaluation of metabolic profile in patients with chronic obstructive pulmonary disease and correlation between the metabolic parameters and the severity of disease Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006 OSA as a cause of cardiovascular disease, including heart failure Source: ERS Conference Year: 2015 Assessment of aortic stiffness which is a new cardiovascular morbidity and mortality predictor in patients with obstructive sleep apnea syndrome and relation with severity of the disease Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 The cardiovascular  comorbidity and the risk of stroke by means of CHADS2- VASc scale  in patients with chronic obstructive pulmonary disease. Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017 High prevalence of undiagnosed COPD in patients with cardiovascular disease Source: Annual Congress 2009 - Risk factors for COPD Year: 2009 Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Metabolic consequences of obesity as an “outside in” mechanism of disease severity in asthma Source: Eur Respir J 2016; 48: 291-293 Year: 2016 Assessment of 10-year risk for cardiovascular disease in patients with overlap syndrome Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018